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Abstract
Background: Severe malaria has been attributed to the expression of a restricted subset of the var multi-gene
family, which encodes for Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1). PfEMP1 mediates
cytoadherence and sequestration of infected erythrocytes into the post-capillary venules of vital organs such as the
brain, lung or placenta. var genes are highly diverse and can be classified in three major groups (ups A, B and C)
and two intermediate groups (B/A and B/C) based on the genomic location, gene orientation and upstream
sequences. The genetic diversity of expressed var genes in relation to severity of disease in Tanzanian children
was analysed.
Methods: Children with defined severe (SM) and asymptomatic malaria (AM) were recruited. Full-length var mRNA
was isolated and reversed transcribed into var cDNA. Subsequently, the DBL and N-terminal domains, and
up-stream sequences were PCR amplified, cloned and sequenced. Sequences derived from SM and AM isolates
were compared and analysed.
Results: The analysis confirmed that the var family is highly diverse in natural Plasmodium falciparum populations.
Sequence diversity of amplified var DBL-1α and upstream regions showed minimal overlap among isolates,
implying that the var gene repertoire is vast and most probably indefinite in endemic areas. var DBL-1α sequences
from AM isolates were more diverse with more singletons found (p<0.05) than those from SM infections.
Furthermore, few var DBL-1α sequences from SM patients were rare and restricted suggesting that certain PfEMP1
variants might induce severe disease.
Conclusions: The genetic sequence diversity of var genes of P. falciparum isolates from Tanzanian children is large
and its relationship to disease severity has been studied. Observed differences suggest that different var genes
might have fundamentally different roles in the host-parasite interaction. Further research is required to examine
clear disease-associations of var gene subsets in different geographical settings. The importance of very strict
clinical definitions and appropriate large control groups needs to be emphasized for future studies on disease
associations of PfEMP1.
Keywords: Plasmodium falciparum, Severe malaria, var genes, PfEMP1, Expression, Diversity
* Correspondence: hans-peter.beck@unibas.ch
2Swiss Tropical and Public Health Institute, Socinstrasse 57 Postfach, Basel
4002, Switzerland
3University of Basel, Switzerland
Full list of author information is available at the end of the article
© 2012 Mugasa et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Mugasa et al. Malaria Journal 2012, 11:230
http://www.malariajournal.com/content/11/1/230
Background
Despite all efforts to curb Plasmodium falciparum mal-
aria infections it still is an important cause of morbidity
and mortality in many developing countries, with an
estimated 700,000 deaths annually [1]. The burden of
disease is highest in children below five years of age
where much of the mortality is attributable to severe
malaria. Except for RTS,S, which is currently in clinical
phase 3 trial, no vaccine is available to date, but vaccine
development is encouraged by the fact that children liv-
ing in endemic areas attain conditional immunity to se-
vere malaria after a relatively few number of episodes
during childhood [2]. Genetic diversity of different para-
sites and antigenic variation of surface antigens pose an
obstacle for vaccine development.
Severe malaria, the most life threatening form of the
disease is believed to be mediated by cytoadhesion of
P. falciparum-infected erythrocytes to a variety of recep-
tors on the endothelial lining of the host’s blood capillar-
ies. This post-capillary sequestration severely affects vital
organs such as the brain, kidneys, lungs or placenta [3].
Cytoadherence is conferred by P. falciparum derived
proteins on the surface of infected erythrocytes that play
a key role as both virulence factors and as targets of nat-
urally acquired immunity [4,5]. Of these, the major con-
tributor to pathology of P. falciparum is the P.
falciparum erythrocyte membrane protein 1 (PfEMP1).
PfEMP1 is a large protein of approx. 200–400 kDa, it is
a highly polymorphic antigen which is encoded by a
family of ~60 var genes per haploid genome [6]. Var
genes present with a two-exon structure encoding a semi-
conserved C-terminus that contains a predicted trans-
membrane region, and a highly polymorphic extracellular
N-terminus. This part has a modular structure contain-
ing various numbers of Duffy-binding-like (DBL)
domains and cysteine-rich domains that have been
shown to be involved in sequestration of the infected
erthrocytes [7-9]. The most N-terminal sequence includ-
ing the DBLα domain is the most conserved domain
within the var gene domains also conferring cytoadher-
ence [10,11]. A range of host receptors have been shown
to interact with PfEMP1 thus determining the binding to
various tissues [10,12,13]. Rosetting and sequestration
conferred by expression of different PfEMP1 molecules
has been implicated in severe disease [14].
var genes have been classified into three major groups
(A, B and C) and two intermediate groups (B/A
and B/C) based on the presence of one of the 5′ up-
stream sequences (upsA, B or C), and the position and
orientation of the gene within a genomic context
[15,16]. It has been speculated that severe malaria is
determined by the expression of a restricted and antige-
nically semi-conserved subset of PfEMP1 [17,18]. The
best understood host-parasite interaction concerning
PfEMP1 is pregnancy-associated malaria (PAM) in
which PfEMP1 molecules binding to CSA are involved
[19]. var genes have further been sub-classified by the
distribution of cysteines throughout the head structures
and positions of limited variation (PoLV) [20].
Few studies have investigated the expression of var
genes in field isolates representing different forms of se-
vere malaria [21-27]. These studies suggested that the
transcription patterns of var genes vary between differ-
ent malaria manifestations. Differences in epidemiology,
severe disease classification, and var classification have
also made comparison between studies difficult. Using
quantitative real time reverse transcription PCR (qRT-
PCR), we have previously shown that group A and B var
transcripts were up-regulated in children from Tanzania
with severe malaria as opposed to asymptomatic infec-
tions [25]. Although qRT-PCR is a standard method for
detection and quantification of gene expression levels
[28], without subsequent sequencing this technique is
not informative to study diversity of genes. Given the
importance of immunity against PfEMP1 and its possible
association with protection against malaria, it is essential
to gain amore detailed understanding of diversity of
these molecules at sequence level. Only this allows the
determination of how such diversity influences the de-
velopment of protective immunity. In this study, the
genetic diversity of expressed PfEMP1 molecules in
parasite populations directly isolated from children with
severe malaria was examined.
Methods
Sample collection
Samples used in this study were collected in a severe mal-
aria (SM) case control study that has been described in
detail previously [25]. Briefly, children aged <59 months
admitted with severe malaria according to WHO guide-
lines [29] at Saint Francis Referral Hospital (StFRH),
Ifakara, Tanzania were recruited into the study after
informed consent was obtained from children’s parents
or guardians. Exclusion criteria were: confirmed co-
infections, malnutrition (mid-upper arm circumference
[MUAC] of ≤12 cm), haemoglobin ≤5 g/dL, lactate
≥5 mmol/L, glucose ≤2.2 mmol/L, or anti-malarial
treatment during the last 14 days. A total of 52 patients
with SM were recruited. From eight patients meeting the
inclusion criteria, cDNA could be obtained and these
were grouped as cerebral malaria cases according to
WHO guidelines [29] and the modified blantyre coma
score ≤3 [30]. Controls were children from nearby villages
with asymptomatic malaria (AM) defined as presence of
P. falciparum, axillary temperature of ≤37.5°C and no
other symptoms. Children aged <59 months were
screened for P. falciparum infection by using a rapid diag-
nostic test (RDT), (ParacheckW Pf, Orchid Biomedical
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Systems, Goa, India). Participating children who were
found positive by RDT were subsequently confirmed
microscopically by Giemsa-stained thick and thin blood
film at IHI laboratory. A total of 19 children were initially
recruited into the control group, of which only seven
could be confirmed P. falciparum positive by microscopy.
Ethical clearance for this study was obtained from the Ifa-
kara Health Institute and the Medical Research coordinat-
ing committee of the National Institute for Medical
Research in Tanzania.
From all participating children, one to two ml of venous
blood was drawn into an EDTA tube (Vacutainer, Becton
Dickinson, Rutherford, NJ, USA). Between 50 – 100 μL of
whole blood was immediately mixed with 2 volumes of
6 m guanidine HCl, 50mMTris pH 8.0, 20 mM EDTA
and kept at −20°C for gDNA isolation. The remaining ery-
throcytes (RBC) were separated from serum by centrifu-
gation and washed with 40 ml phosphate buffered saline,
5 volumes TRIzol reagent (Invitrogen) were added to the
RBC pellet before preservation at −70°C until later use.
DNA extraction and genotyping
Genomic DNA was extracted from frozen blood in
guanidine HCl using QiaAmp blood kit (Qiagen) follow-
ing the manufacturer’s instructions. The minimum num-
ber of genotypes per isolate was determined by msp2
PCR amplification and subsequent Genescan analysis as
described by Falk et al. [31]. Briefly, 1 μL of purified
genomic DNA was used in a 20 μL primary PCR reac-
tion, followed by a nested PCR reaction using
fluorochrome-labelled primers for both msp2 allelic fam-
ilies. Capillary electrophoresis was used to determine the
number of infecting strains per isolate.
Isolation of full-length var transcripts and RT- PCR
Total RNA was extracted by using TRIzol reagent
(Invitrogen) twice as recommended by the manufac-
turer to decrease DNA contamination. Between TRIzol
purifications RNA was treated with 3 U of RQ1 RNase-
free DNase (Promega). Full-length var mRNA was
isolated by using magnetic beads tagged with an oligo-
nucleotide complementary to the acidic terminal sequence
(ATS) as previously described [23] with modifications.
Briefly, RNA was dissolved in 5 mM Tris, 0.5 mM EDTA,
and mixed with binding buffer (0.5 M LiCl, 1 mM EDTA,
10mM Tris, pH 7.5), 15 mM DTT, 40 U RNaseOUT
(Invitrogen) and 1 pmol of biotinylated oligonucleotide
complementary to the conserved sequence in the ATS do-
main (Biotin-5'-GGTTC(A/T)A(A/G)TAC(C/T)ACTTC
(A/T)AT(C/T)CCTGGT(A/G)CATATATATCATTAA-
TATCCAATTCTTCATA(C/T)TCACTTC(T/G)GA
(A/T/G)GA-3′). This mixture was incubated 65°C for 30
minutes and afterwards kept at 4°C. Meanwhile 150 mg
of Dyna beads m-280 streptavidin (Dynal Biotech, ASA,
Oslo, Norway) was washed as suggested by the manufac-
turer and resuspended in 0.5 M LiCl and added to the
oligonucleotide-RNA hybrids. The mixture was uniformly
mixed by rotating for 30 min at 37°C. The biotinylated
beads-ATS-mRNA complex was washed three times with
washing buffer (10 mM Tris, 1 mM EDTA, 0.15 mM
NaCl, pH 7.5) and once with 10 mM Tris. Reverse tran-
scription (RT) into single stranded cDNA was performed
on captured mRNA, primed by random hexamere oligo-
nucleotides in the concentration of 300 ng (Invitrogen)
using Sensiscript reverse transcriptase (Qiagen) following
the manufacturer’s protocol in a final volume of 20 μL. A
second RNA aliquot was treated equally but reverse tran-
scriptase was omitted in the RT-step. This sample served
as a control for proving the absence of gDNA. After RT,
cDNA was treated with RNaseA (Promega) and 1 μL was
used for subsequent PCR analyses.
Amplification of var sequences
The DBL-1α domain of var genes was PCR amplified
from 1 μL cDNA using Advantage cDNA polymerase
mix (CLONTECH) and the primer sets shown in Table 1.
Table 1 Oligonucleotide primers used for amplification of different fragments of var genes
var Gene region Size of amplified product Tanneal Name of primer Primer sequence Source
DBL1α ~500 54 DBLα-5′ 5′-GCACGAAGTTTTGCAGATAT(A/T)GG-3′3′- [23]
DBLα-3′ AA(A/G)TCTTC(T/G)GCCCATTCCTCGAACCA-5′
DBL1α-CIDR 1.5 kb 52 DBLα-5′ 5′-GCACGAAGTTTTGCAGATAT(A/T)GG-3′ [23]
CIDR1.1-3′ 3′-T(C/G/T)TAGTAATTTATC(A/C/T)ATTGT-5′
CIDR1.2-3′ 3′-T(C/G/T)TAATAAGAATTCGATTGC-5′
upsA 5′UTR- DBL1α 1.2 kb 54 upsA-5′ 5′-ATTA(C/T)ATTTGTTGTAGGTGA-3′
DBLα-3′ 3′-AA(A/G)TCTTC(T/G)GCCCATTCCTCGAACCA-5′
upsB 5′UTR- DBL1α 1.3 kb 52 17DBLα-5′ 5′-ATGTAATTGTTGTTTTTTTTTTTGTTAGAATATTTAAA-3′
DBLα-3′ 3′-AA(A/G)TCTTC(T/G)GCCCATTCCTCGAACCA-5′
psC 5′UTR- DBL1α 1.3 kb 54 5B1-5′ 5′-CACATATARTACGACTAAGAAACA-3′ [15]
DBLα-3′ 3′-AA(A/G)TCTTC(T/G)GCCCATTCCTCGAACCA-5′ [23]
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PCR was performed in 25 μL 1.5 mM MgCl2, 200 μM
dNTP mix, 1 μM each primer. The cycling conditions
were 30 cycles of 94°C for 30 s, 1 min at the annealing
temperature specified in (Table 1) and for 70 s at 68°C.
This generated a PCR product of about ~ 400–500 bp in
length.
Three different PCRs were carried out on cDNA to de-
termine the genetic diversity in the upstream sequences
using three degenerate forward primers based on se-
quence alignments of 3D7 var genes (Table 1). These pri-
mers amplify homology blocks in the upstream sequences
with following sizes: 200 bp for upsA, 400 bp for upsB,
and 440 bp for upsC. The reverse primer was chosen
from the homology block H of the first DBL-1α domain
[32]. Primers were tested on genomic DNA from the 3D7
isolate. Amplification of DBLα-CIDRβ fragments was car-
ried out using primers shown in Table 1. Controls without
reverse transcriptase were amplified in parallel for each
reaction, and if a PCR product was obtained the RT(+)
sample was discarded and excluded from the analysis.
Cloning and sequencing
An aliquot of 5 μL of each PCR product was visualized in
a 1% agarose gel, the remaining PCR product was purified
using the NucleoSpinW Extract II kit (Macherey & Nagel).
The eluted DBL-1α fragments were cloned into the
pGEM-T vector (Promega) according to the manufac-
turer’s instructions and transfected into E.coli SURE cells
(Stratagene). 5′ upstream regions and DBL-1α-CIDR1
products were cloned into the pCRW4-TOPO vector (Invi-
trogen) and transformed into E.coli TOP10 cells. This
vector was more suitable for large fragments (> 1 kb) and
for PCR products with low concentration (< 5 ng/μL).
From each cloning reaction an average of 50 colonies
found positive by PCR screening were further processed
for sequencing using the PerfectprepW Plasmid 96 Vac
Direct bind kit (Eppendorf). The size of each insert was
checked from purified plasmids using restriction enzymes
NotI and NcoI (New England BioLab) for pGEMT plas-
mids. EcoRI digests (New England BioLab) were used for
TOPO plasmids. Sequencing was carried out using the T7
and SP6 primers for pGEM-T vector, whereas M13 for-
ward and reverse primers were used for the pCRW4-
TOPO using a 96 capillary automated sequencing systems
3700 (Applied Biosystems). A multiple-sequence align-
ment of sequences derived from the same clinical isolate
was carried out to allow the exclusion of PCR derived
mutations. Two sequences were considered to be identical
when ≥96% amino acid sequence identity was detected.
Sequence analysis
DNA sequences were assembled and analyzed using
ContigExpress in the Vector NTI Advance™ 10 software
(Invitrogen) and BLAST from the NCBI webpage
(http://www.ncbi.nlm.nih.gov/BLAST/). BLAST analysis
against the 3D7 genome database was performed using
the PlasmoDB interface (https://www.pasmoDB.org
[33]). DNA sequences were translated using RevTrans1.4
[34]. Amino acids were aligned with either CLUSTALW
1.8 or MUSCLE [35] using default parameters and edited
with Bioedit version 7.09 with minor manual adjustment
where necessary. Sequences were further categorized
into sequence types (STs) by BLASTCUT analysis [36]
by which sequences sharing ≥96% sequence identity
were assigned the same ST.
Phylogenetic analysis
Phylogenetic analyses were conducted on multiple se-
quence alignments of the 3 most dominant sequences
from each isolates. Because var genes are subject to intra-
genic recombination [37], synonymous substitutions are
likely to be saturated and DNA sequence analysis would
be quite noisy in constructing phylogenetic trees [38].
Therefore, we used protein sequences rather than nucleo-
tide sequences. Two methods were employed in con-
structing the phylogenic trees. Neighbour-Joining (NJ)
trees were constructed by using MEGA 4.0 [39]. The reli-
ability of internal branches for NJ was assessed with 1,000
bootstrap pseudo-replicates using ‘pairwise deletion op-
tion’ of amino acid sequences with p-distance. SplitsTree4
version 4.7 was used to construct the phylogenetic net-
work [40] using the Neighbour-Net distances transform-
ation and equal angle splits transformation.
Results
Sample collection and clinical data
A total of 15 children were used in the analysis of the
present study of which 8 were in the SM group with
cerebral manifestation, Blantyre score ≤3 and 7 children
with asymptomatic P. falciparum malaria were in the
control group. Clinical and epidemiological assessments
of all subjects are presented in Table 2. There was a sig-
nificant difference in age between AM cases (median 52,
range 24–59) and SM cases (median 28.5, range 14–40,
p = 0.02, Kruskal-Wallis test). There was also a highly
significant differences in parasitaemia between both clin-
ical categories (p =0.0012, Kruskal-Wallis test).
Multiplicity of infection
msp2 genotyping indicated that 87.5% (7/8 SM isolates)
had multiple P. falciparum clone infections (2–4clones)
with an average of 2.6 infecting clones. All isolates from
AM children had multiple infections (2 or 3) with an
average of 2.4 infecting clones (Table 3).
DBL-1α sequence types
A total of 615 var DBL-1α clones (~ 400–500 bp) were
successfully sequenced. Of these, 305 sequences were
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originating from AM children (Table 3) and were
assembled into 131 sequence types (STs) i.e. distinct
DBL-1α sequences. The remaining 310 sequences from
SM children were assembled into 127 sequence types.
AM patient samples had more singletons (sequences oc-
curring only once) than SM isolates (p<0.05).
Assembled sequence types showed an extreme diversity
in sequence reflecting the high recombination and muta-
tion rates in the DBL-1α domain. Multiple-sequence
alignment of the DBL-1α sequences showed conserved
islands of homology. The dominant sequence from each
isolate was blasted against the 3D7 genome. The blasted
sequence was assigned the name of the identified 3D7
gene with the high scoring segment pair (Table 3). PCR
amplification and cloning efficiency of the var up-stream
regions (upsA, upsB, upsC and DBL1α-CIDR) were very
low and few sequences could be generated. These
sequences were, therefore, excluded from the analysis.
Distribution of DBL-1α expressed sequence tags
The number of distinct transcribed DBL-1α var gene
sequences detected per isolate varied from 8 to 25
(Table 3). All isolates showed a predominant sequence as
well as minor transcripts and unique sequence types. The
homologous group A transcript to PFD0020c in 3D7 was
a predominant transcript in ISM 16 and was among the
top three frequent sequences in SM isolates. However, the
transcript homologous to PF08_0141 in 3D7 was the pre-
dominant transcript in 2/7 SM isolates (Table 3). In
cluster analyses some of the DBL-1α sequences were
found to be shared among isolates (i.e overlapping). A
number of transcripts were found in both groups (SM &
AM) and others were specifically found either in SM or
in AM isolates. Some sequences were unique to a particu-
lar isolate and were not found in other isolates. The distri-
butions of the STs in our 15 isolates are shown in
Figure 1. There was no significant difference in the num-
ber of distinct DBL-1α sequences per isolate detected in
both clinical groups AM: median 20, range 8–25, SM:
median 17.5, range 12–23, (P= 0.72, Kruskall-Wallis test).
Distribution of DBL-1α expressed sequences tags in
clinical isolates
All sequences generated were classified into six DBL-1α
sequence tag groups by using text string software in MS
Excel and Perl which was kindly provided by Dr P Bull
(KEMRI, Kilifi, Kenya). This classification of DBL-1α se-
quence tags was previously explained in detail by Bull
et al. [20]. In summary, it is based on counting the num-
ber of cysteine-residues within the tagged region, and in
a set of sequence motifs at four positions of limited vari-
ability (PoLV 1–4). Figure 2 shows the distribution of
PoLV/cys groups in clinical isolates. Analysis of DBLα
sequences generated in the present study corresponded
well with the cysteine/PoLV grouping. Figure 3 shows
the proportional distribution of PoLV motifs between
the clinical isolates. Sequence ‘signature tags’ and the
dominant sequence group from each isolate are shown
Table 2 Clinical and epidemiological assessment of isolates from severe and asymptomatic malaria
Isolate Sex Age
(months)
Days between
symptoms and
treatment
Parasitemia
(parasites/200
leukocytes)
Temperature
(°C)
MUAC
(cm)
PCV% Lactate
mmol/L
Glucose
mmol/L
Blantyre
score
Severe
ISM2 M 40 3 3120 38.6 17 27 2.5 2.3 2
ISM3 M 36 2 2574 39.7 17 16 2.4 5.9 3
ISM11 M 33 2 7344 37.0 17 30 4.5 3.7 3
ISM16 M 16 3 2484 38.6 14 26 2.1 2.7 3
IMS33 F 24 3 1316 37.4 16 22 3.1 3.0 2
ISM48 M 36 2 4713 38.9 17 31 3.0 5.0 3
ISM49 M 14 4 1907 39.9 16 23 1.8 6.6 3
ISM51 F 16 4 9999 40.0 16 21 5.0 8.4 2
Asymptomatic
IAM5 M 24 NA 830 36.7 ND 20 3.4 5.8 NA
IAM7 F 33 NA 704 36.6 ND 14 3.3 3.9 NA
IAM10 M 59 NA 70 37.5 ND 22 2.4 4.2 NA
IAM11 F 56 NA 68 36.7 ND 23 4.6 4.4 NA
IAM12 F 47 NA 690 36.4 ND 26 4.5 8.0 NA
IAM17 M 59 NA 360 37.3 ND 28 2.5 4.9 NA
IAM18 F 52 NA 360 37.3 ND 18 3.1 4.3 NA
NA Not applicable, ND Not determined.
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in Table 3. A significant association of cys2 sequence tags
(groups 1–3) with SM isolates (p<0.0001, CMH test),
with an odds ratio of 2.5 (95% CI= 1.78-3.4) was observed.
These findings support previous reports that DBL-1α
sequences associated with severe disease have a reduced
number of cysteines [21-23]. A two-sample test of propor-
tion showed that expressed PoLV motifs were associated
with a particular disease phenotype (p<0.0001). These
PoLV motifs were found strongly associated with severe
malaria: in PoLV1 (LDLY and MFKR), in PoLV2 (FREY
and LREV), in PoLV3 (NAIT and RAIT), and in PoLV4
(LTNL and PTNL).
Cumulative diversity of DBL-1α sequences in clinical
isolates
To estimate the size of the var gene repertoire in the
parasite population under study, the rate at which dis-
tinct DBL-1α sequences changed was simulated with in-
creasing sample size. This simulation was performed
separately for AM and SM, as well as the combined data
(AM & SM). The empirical plots were fitted by a linear
function. The curves did not plateau with the DBL-1α
sequences generated from the Ifakara area (Figure 4).
The repertoire of expressed var genes was unlimited.
Thus, var gene diversity in this local population seems
Table 3 Summary of analysed sequences of different transcribed var DBL1α sequences
Isolates RT-PCR, cloned in
pGEMT Vector, PCR
screened 96 clones
picked for sequencing
Sequences
generated
per isolate
Number of
distinct DBLα
var per isolate
Predominant
gene blasted
vs 3D7
Group
homology
to 3D7
Bulls’ signature
and group
MOI
Severe
ISM 2 48 42 23 PF08_0141 A LFLG-IREY-KAIT-2-LTNL 2
ISM 3 48 41 22 PFF0010w B/A LYLD-FREY-KAIT-2-PTNL 3
ISM 11 60 50 20 PFD1005c B/C LFIG-LRED-KALT-4-PTYF 2
ISM 16 48 36 18 PFD0020c A MFKR-LRED-RAIT-2-PTNL 1
ISM 33 60 50 15 PFF0010w A LFLG-VREY-KAIT-2-LTNL 3
ISM 48 48 47 12 PF08_0141 A MFLG-IREY-KALT-2-PTNL 3
ISM 49 48 44 17 PFL1830c B LYLG-LRED-KAIT-4-PTYF 3
Asymptomatic
IAM 5 48 46 25 PF08_0141 A MFLG-IREY-KALT-2-PTNL 3
IAM 7 48 45 8 PFL 1830c B LYLG-LRED-KALT-4-PTYF 2
IAM 10 48 38 23 PFD0615c C LFIG-LRED-EAIT-4-PTNF 3
IAM 11 48 43 15 PFL2665c B LYRG-LRED-NAII-3-LTNF 3
IAM 12 48 45 20 PFL1955w B/C LYLG-LRED-KAIT-4-PTYF 2
IAM 17 48 46 24 PFA0005w B LYLG-LRED-EAIT-4-PTYF 2
IAM 18 48 42 16 PFA0005w B LYLG-LRED-KAIT-4-PTYF 2
Total 615
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Figure 1 Distribution of unique sequence types (STs) of DBL1α in clinical isolates. Blue columns represent STs found in multiple samples
from both AM and SM groups. Red columns represent STs found in multiple samples within the SM group. Pink columns represent STs found in
multiple samples within the AM group. Yellow columns represent STs specific to each individual isolate.
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to be immense and unrestricted. However, a minimal
overlap among var genes was found in different isolates.
A similar finding has been reported by Barry et al. [41]
for the cumulative DBL-1α sequences from genomic
DNA in the Amele, PNG, and for the global population,
where in more than 1,000 sequences from 59 isolates
plus the entire 3D7 var repertoire the saturation point of
the var gene repertoires could not be reached.
Phylogenetic analysis
To study the sequence diversity between the SM and
AM groups, a phylogenetic network was constructed
using the three most dominant DBL-1α variants
expressed from each SM or AM isolate. The analysed
sequences clustered in two distinct groups. The majority
of the DBL-1α isolates from severe malaria clustered to-
gether and belonged to var group A and B/A. AM iso-
lates formed another cluster mainly consisting of var B,
B/C or C (Figure 5). To study further relationships be-
tween sequences, nine DBL-1α sequences from the 3D7
genome were incorporated, three from each group A, B
and C, in the construction of the phylogenetic tree.
Among the sequences included was the group A var
PF11_0008 which has been shown to be highly tran-
scribed in the NF54 isolate [42] and group B var
PF10_0406 which has been detected previously as a
major transcript in 3D7B2 and 3D7B1 samples [43]. The
DBL-1α sequences analysed were found to cluster into
two distinct clades. The majority of SM isolates and the
3D7 DBL-1α sequences clustering together belonged to
Figure 2 Distribution of DBL-1α sequences into cys/PoLV groups by clinical status. SM DBL-1α sequences had more than 50% cys2
sequence tags (1–3 groups) compared to 27% in AM isolates.
Figure 3 Distribution of PoLVmotifs within clinical isolates SM (red bars) and in AM (white bars).
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var group A. AM isolates and the other remaining 3D7
DBL-1α sequences formed another cluster mainly
belonging to var group B, B/C or C (Figure 6).
These findings again support the hypothesis that SM is
caused by a restricted subset of var genes that belong to
var group A or B/A whilst non severe malaria is attribu-
ted to the presence of another var gene group. Similarly,
the phylogenetic approach of Kyriacou et al. [21] using
DBL-1α sequence tags from Mali identified var tran-
scripts from group A and B/A genes to be more frequent
among parasites isolated from children with cerebral
malaria than from patients with hyper-parasitaemia.
A multiple-sequence alignment of three dominant upsA
sequences from clinical isolates together with upsA
sequences from the 3D7 genome showed the existence of
short islands of homology, conserved in all isolates sug-
gesting that they might be structurally important. Phylo-
genetic analysis of the three dominant upsA sequences
from clinical isolates and the 3D7 upsA sequences,
showed an even distribution among clinical isolates
(Figure 7). Two different methods for phylogenetic tree
construction were used (MEGA 4.0 and SplitsTree 4.7)
and both methods yielded similar tree topologies.
Discussion
Studies on var gene diversity are important in under-
standing malaria pathogenesis and in the design of disease
interventions such as a vaccine or chemotherapies. In the
present study, we examined var gene expression from
clinical isolates of children with severe malaria and
asymptomatic infections from Tanzania. In each isolate
dominant expression of one particular var gene was
found, together with less abundant variant transcripts and
unique sequences. However, the dominant sequences dif-
fered between isolates. This suggests that each parasite
contains its own set of var gene variants. This has the
consequences that exposure to multiple infections and
hence var gene products do not necessarily confer im-
munity to future malaria infections [46,47].
By analysing the expressed var gene repertoires in se-
vere malaria cases versus asymptomatic controls, we
showed that the diversity within the var gene family is
enormous with a minimal degree of overlaps between
isolates. Kyriacou et al. [21] have found a minimal over-
lap in var gene repertoires after analysing the expressed
sequence tags from Malian children with malaria infec-
tions. A recent study on molecular epidemiology of var
genes in Africa has also shown a minimal overlap in var
repertoires among parasite genomes [48]. In contrast, Al-
brecht et al. [49] reported a large overlap of the var gene
repertoire in Western Amazon isolates. var repertoires of
natural parasite populations found within specific geo-
graphical regions showed a degree of overlapping, sug-
gesting the circulation of a similar var gene repertoire.
This has important implications for the acquisition of
long-term immunity by the exposed individuals [47].
The diversity of var genes within a natural P. falcip-
arum population in a particular geographical region is
difficult to define, and to assess whether the diversity is
constant due to functional constrain on this molecule,
fluctuating or constantly turning over, and how fast the
turnover rate of the PfEMP1 repertoires could be.
Changes in the var repertoire are believed to be due to
high allelic and ectopic recombination rates of var genes
in field isolates [37,50,51] which are influenced by trans-
mission intensity. The diversity of the PfEMP1 repertoire
of parasites in a given geographical area is a key factor
in the development of clinical immunity. The vast anti-
genic diversity and complexity of var gene repertoires in
parasite populations may explain why individuals are
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Figure 4 Cumulative diversity curves for DBL-1α sequences from Ifakara. The cumulative curve for DBL-1α was determined by simulation
the number of unique sequences as a function of the number of patient samples. For each number of patient samples the statistics value was
obtained from simulations of all possible sample combinations.
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repeatedly susceptible to P. falciparum infections and
never develop sterilizing immunity. The antigenic vari-
ation and high switching rate of var gene expression are
effective mechanisms adopted by P. falciparum to evade
the host’s immune system, for survival, and effective
transmissions.
In this study, several sequences were observed more
frequently than others within individual patients. This is
consistent with previous studies of var gene diversity
[21,22,46,50,51]. The variability of the DBL-1α and up-
stream sequences within an isolate was found to be simi-
lar to different isolates in both the groups (SM & AM).
AM isolates were more diverse as reflected by the pres-
ence of more singletons suggesting that var genes asso-
ciated with asymptomatic infection have an enormous
repertoire which could explain the difficulty of acquiring
immunity to mild or asymptomatic malaria.
Isolates from children with severe malaria were pre-
dominantly found to transcribe var genes with a DBL-1α
domain that had a reduced number of cysteine residues
which is the characteristic of var group A. Similar
results have been reported previously from other re-
search groups in Kenya, Mali, and Brazil [20-22]. This
supports the notion that severe malaria might be caused
Figure 5 Phylogenetic network showing the comparison of 3 dominant DBL-1α sequence tags transcribed from clinical isolates,
generated using Neighbour-Net [44]. Sequences transcribed by isolates with severe malaria (ISM, blue) and asymptomatic malaria (IAM, red)
are compared. The sequences fall into two major clades separated with dotted lines, the upper cluster formed 2 subgroups of sequences isolated
from severe patients, one with group A and the remaining var group B/A homology to 3D7. The majority of sequences from asymptomatic
patient isolates clustered together and were homologous to group B, B/C and C of the 3D7 genome.
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Figure 6 Phylogenetic comparison of 3 dominant DBLα sequence tags transcribed from each clinical isolates and selected tags from
3D7. A neighbor-joining tree was generated using amplified DBL-1α fragments. The bootstrap consensus tree inferred from 1000 replicates [45],
using pairwise deletion of amino acid sequences with p-distance. Phylogenetic analyses were conducted in MEGA4 [39]. Sequences transcribed
by isolates from children with severe malaria (ISM, pink), asymptomatic malaria (IAM,black) and 3D7 genes (group A, red; group B, blue; group C,
green).
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by a restricted subset of var genes and confirms that
group A var genes are involved in severe disease simi-
larly as we had shown in a previous study that group A
var genes were up regulated in children with cerebral
malaria [25]. However, most studies on var gene diver-
sity have been relying on the use of DBL-1α fragments
[50]. DBL-1α primers amplify only a small fragment of
the var gene that is more conserved than other var
domains and that is found in most of PfEMP1 proteins.
Due to the complex nature of var genes, only recently
complete var genes could be cloned routinely [52] and
could provide in future additional information on under-
standing var gene transcription and its association to
disease phenotype.
Cluster analysis revealed several ‘unique sequences’ of
var genes which were transcribed only in isolates from
patients with severe malaria. Expression of these ‘unique
sequences’ in a patient who lacks a pre-existing antibody
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 PF11 0008
 ISM16upsAE3
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 PF08 0141ISM2upsAD10
MAL7P1.1
PFD1235w
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Figure 7 Phylogenetic comparison of var group A from 3D7 genome and 3 dominant var group A amplified from clinical isolates. A
neighbor-joining tree was generated based upon the predicted protein start site in the N-terminal segment (NTS) domain to the first DBL-1α H
block. The bootstrap consensus tree inferred from 1000 replicates [44], using pairwise deletion of amino acid sequences with p-distance.
Phylogenetic analyses were conducted in MEGA4 [39]. Sequences transcribed by isolates from children with severe malaria (ISM, blue),
asymptomatic (AS, green).
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response against this variant might trigger the develop-
ment of severe malaria. Once exposed to these potentially
virulent var genes individuals living in endemic areas may
acquire immunity to severe malaria. In areas of high en-
demicity this might happen early in life after only a few
clinical episodes. The distribution of PoLV motifs showed
8 motifs which were highly associated with severe disease.
Based on the MOTIFF algorithm, Normark et al. [53]
identified 15 DBL-1α degenerate sequence motifs pertin-
ent to severe disease and three motifs associated with the
high rosetting phenotype after analysing 93 patients with
well-characterized disease. Once again pointing in the dir-
ection that disease phenotypes are correlated with the ex-
pression of certain PfEMP1 variants and motifs. This is
highly relevant information for vaccine development and
understanding disease pathogenesis.
The distribution of PF11_0008, a group A var gene,
which previously has been identified in the 3D7 genome
and the isogenic isolate NF54 [42], was found in three
SM isolates (ISM11, ISM33, ISM48) and in one AM
sample (IAM17), although in low frequencies. This, and
the observation that PFD0020c also has been more fre-
quently found in SM cases suggests that the var genes of
laboratory strains are shared among the field isolates.
The recent report by Claessens et al. [54] showing that
up-regulation of the group A var gene 3D7_PFD0020c is
associated with adhesion to human brain endothelial
cells further supports this notion.
Conclusion
The var family is highly diverse in natural P. falciparum
populations, but this diversity was more restricted in se-
vere malaria than in asymptomatic isolates, and this
finding suggests a fundamental role played by different
subsets of var transcripts in disease syndromes. Further
analysis of this molecule is required from many geo-
graphical regions with well-defined malaria infections.
Such an approach might provide the basis for an innova-
tive vaccine or chemotherapy intervention. To gain bet-
ter understanding of var gene diversity and function
future work should be focused on analysis of full-length
sequences and the analysis of protein function and im-
munological responses.
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